Target intelligence / Profile preview

Ribosomal protein L36a pseudogene 32 (RPL36AP32)

Target: RPL36AP32
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L36a pseudogene 32 (RPL36AP32) is a pseudogene in the human genome and is not known to encode a functional protein product[1][6][7]. Pseudogenes are genomic DNA sequences similar to normal genes but typically nonfunctional due to mutations or truncations that prevent normal gene expression or translation[6][9]. RPL36AP32 is related by sequence to the functional ribosomal protein L36a gene but is considered noncoding, and there are no known biological functions, disease associations, or interactions with drugs documented for this sequence[6][7]. There are no data supporting its consideration as a therapeutic target, biomarker, or involvement in pathological processes[6][7].

Other names: RPL36A_12_887RPL36AP32

Beyond the preview

Go deeper on Ribosomal protein L36a pseudogene 32 (RPL36AP32).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L36a pseudogene 32 (RPL36AP32).

Explore the full profile